Search Results

There are 7740 results for: content related to: The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy

  1. You have free access to this content
    Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

    Intervention Review

    The Cochrane Library

    Frank Kunath, Henrik R Grobe, Gerta Rücker, Edith Motschall, Gerd Antes, Philipp Dahm, Bernd Wullich and Joerg J Meerpohl

    Published Online : 30 JUN 2014, DOI: 10.1002/14651858.CD009266.pub2

  2. Bicalutamide (Casodex®) in the treatment of prostate cancer: History of clinical development

    The Prostate

    Volume 34, Issue 1, 1 January 1998, Pages: 61–72, Geert J.C.M. Kolvenbag, George R.P. Blackledge and Karen Gotting-Smith

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(19980101)34:1<61::AID-PROS8>3.0.CO;2-N

  3. You have free access to this content
    Hormonal therapy options for prostate-specific antigen-only recurrence of prostate cancer after previous local therapy

    BJU International

    Volume 95, Issue 3, February 2005, Pages: 285–290, Judd W. Moul and Alexandre R. Zlotta

    Version of Record online : 28 JAN 2005, DOI: 10.1111/j.1464-410X.2005.05284.x

  4. Bicalutamide dosages used in the treatment of prostate cancer

    The Prostate

    Volume 39, Issue 1, 1 April 1999, Pages: 47–53, Geert J.C.M. Kolvenbag and Anthony Nash

    Version of Record online : 3 MAR 1999, DOI: 10.1002/(SICI)1097-0045(19990401)39:1<47::AID-PROS8>3.0.CO;2-X

  5. You have free access to this content
    Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

    BJU International

    Volume 98, Issue 3, September 2006, Pages: 563–572, CHRIS J. TYRRElL, PETER IVERSEN, TEUVO TAMMELA, JOHN ANDERSON, THOMAS BJÖRK, AMIR V. KAISARY and THOMAS MORRIS

    Version of Record online : 8 JUN 2006, DOI: 10.1111/j.1464-410X.2006.06275.x

  6. Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study

    Histopathology

    Volume 38, Issue 3, March 2001, Pages: 195–201, E Morgante, R Gradini, M Realacci, P Sale, G D'eramo, G A Perrone, M R Cardillo, E Petrangeli, Ma Russo and F Di Silverio

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2559.2001.01077.x

  7. You have free access to this content
    The role of antiandrogen monotherapy in the treatment of prostate cancer

    BJU International

    Volume 91, Issue 5, March 2003, Pages: 455–461, J. Anderson

    Version of Record online : 26 FEB 2003, DOI: 10.1046/j.1464-410X.2003.04026.x

  8. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 875–885, Christian Thomas, Latif A. Wafa, Francois Lamoureux, Helen Cheng, Ladan Fazli, Martin E. Gleave and Paul S. Rennie

    Version of Record online : 5 OCT 2011, DOI: 10.1002/pros.21490

  9. You have free access to this content
    Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: Informed scheduling of the bioreductive drug AQ4N improves treatment response

    International Journal of Cancer

    Volume 132, Issue 6, 15 March 2013, Pages: 1323–1332, Louise Ming, Niall M. Byrne, Sarah Nicole Camac, Christopher A. Mitchell, Claire Ward, David J. Waugh, Stephanie R. McKeown and Jenny Worthington

    Version of Record online : 23 NOV 2012, DOI: 10.1002/ijc.27796

  10. You have free access to this content
    Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1082–1088, Vivek K. Wadhwa, Robin Weston and Nigel J. Parr

    Version of Record online : 13 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08956.x

  11. You have free access to this content
    Learning From Estrogen Receptor Antagonism: Structure-Based Identification of Novel Antiandrogens Effective Against Multiple Clinically Relevant Androgen Receptor Mutants

    Chemical Biology & Drug Design

    Volume 79, Issue 3, March 2012, Pages: 300–312, Bing Liu, Guoyan Geng, Rongtuan Lin, Cuiyan Ren and Jian Hui Wu

    Version of Record online : 11 JAN 2012, DOI: 10.1111/j.1747-0285.2011.01290.x

  12. You have free access to this content
    Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

    BJU International

    Volume 97, Issue 2, February 2006, Pages: 247–254, DAVID G. MCLEOD, PETER IVERSEN, WILLIAM A. SEE, THOMAS MORRIS, JON ARMSTRONG, MANFRED P. WIRTH and the Casodex Early Prostate Cancer Trialists’ Group

    Version of Record online : 20 DEC 2005, DOI: 10.1111/j.1464-410X.2005.06051.x

  13. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides

    Peptide Science

    Volume 90, Issue 5, 2008, Pages: 595–603, Jason Hodoniczky, Colette G. Sims, Wayne M. Best, Jacqueline M. Bentel and Jacqueline A. Wilce

    Version of Record online : 19 MAR 2008, DOI: 10.1002/bip.20986

  14. You have free access to this content
    Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1074–1081, Peter Iversen, David G. McLeod, William A. See, Thomas Morris, Jon Armstrong, Manfred P. Wirth and on behalf of the Casodex Early Prostate Cancer Trialists’ Group

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1464-410X.2010.09319.x

  15. You have free access to this content
    Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1729–1735, Mari Nakabayashi, Lilian Werner, Kevin D. Courtney, Geoffrey Buckle, William K. Oh, Glen J. Bubley, Julia H. Hayes, Douglas Weckstein, Aymen Elfiky, Danny M. Sims, Philip W. Kantoff and Mary-Ellen Taplin

    Version of Record online : 29 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11456.x

  16. You have free access to this content
    Enantiomer Selective Glucuronidation of the Non-Steroidal Pure Anti-Androgen Bicalutamide by Human Liver and Kidney: Role of the Human UDP-Glucuronosyltransferase (UGT)1A9 Enzyme

    Basic & Clinical Pharmacology & Toxicology

    Volume 113, Issue 2, August 2013, Pages: 92–102, Laurent Grosse, Anne-Sophie Campeau, Sarah Caron, Frédéric-Alexandre Morin, Kim Meunier, Jocelyn Trottier, Patrick Caron, Mélanie Verreault and Olivier Barbier

    Version of Record online : 20 MAY 2013, DOI: 10.1111/bcpt.12071

  17. You have free access to this content
    Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer

    BJU International

    Volume 107, Issue 12, June 2011, Pages: 1923–1929, Vivek K. Wadhwa, Robin Weston and Nigel J. Parr

    Version of Record online : 15 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09726.x

  18. You have free access to this content
    Androgen Deprivation for Prostatic Carcinoma: A Rationale for Choosing Components

    International Journal of Urology

    Volume 5, Issue 4, July 1998, Pages: 303–311, Richard Olivier Fourcade and Christian Chatelain

    Version of Record online : 2 JUL 2007, DOI: 10.1111/j.1442-2042.1998.tb00356.x

  19. You have free access to this content
    Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  20. Bicalutamide-Associated Fulminant Hepatotoxicity

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1071–1075, Dr. Cindy L. O'Bryant, Dr. Thomas W. Flaig and Dr. Kenneth J. Utz

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1071